A review article discussed the expanding role of biologics in treating components of metabolic syndrome, including glucagon-like peptide 1 (GLP-1) analogs for type 2 diabetes and obesity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback